×
<- Back

Management of Rheumatoid Arthritis in patients who are inadequately responding to cDMARDS.

  • : Sydney NSW 2000

This activity will focus on the management of existing patients diagnosed with RA who are showing incomplete response to conventional disease-modifying antirheumatic drugs (cDMARD) and will look at the European League Against Rheumatism (EULAR) guideline recommendations for the initiation and management of Janus kinase inhibitors (JAKis) compared to the current standard of care.

Learning outcomes

By the end of this activity, participants will be able to:

  • Outline the importance of identifying patients with RA who are showing incomplete response to cDMARD therapy
  • Discuss the benefits of initiating JAKis in cDMARD-IR patients as first line targeted therapy
  • Summarise the efficacy and safety profile of JAKis and compare to current standard of care.
Delivery
Title
Management of Rheumatoid Arthritis in patients who are inadequately responding to cDMARDS.
Interest Areas / Topics Covered
Rheumatology
Location
Provider Type
Education Provider
Duration
1 Hour
CPD Points
One Category 1 credit
Price
Free
Location
Sydney NSW 2000
Posted By
Contact Phone
Log in into view this field.
Reference
PP-BA-AU-0507
486 Views
Similar Listings
HealthcareLink